Zhang, Wenjing
Nery, Fabiano G.
Tallman, Maxwell J.
Patino, L. Rodrigo
Adler, Caleb M.
Strawn, Jeffrey R.
Fleck, David E.
Barzman, Drew H.
Sweeney, John A.
Strakowski, Stephen M.
Lui, Su http://orcid.org/0000-0003-3541-1769
DelBello, Melissa P.
Funding for this research was provided by:
National Institute of Mental Health (P50 MH077138, 5R01MH080973)
National Natural Science Foundation of China (81671664, 81621003)
Postdoctoral Interdisciplinary Research Project of Sichuan University (0040204153248)
Miaozi Project in Science and Technology Innovation Program of Sichuan Province
1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC08001, ZYJC18020)
Article History
Received: 30 August 2019
Accepted: 23 January 2020
First Online: 1 February 2020
Compliance with ethical standards
:
: Dr. Nery’s spouse is an employee of Eli Lilly and Co. Dr. Patino has received research support through the American Academy of Child and Adolescent Psychiatry through the Junior Investigator Award program. Dr. Adler has received research support from Johnson and Johnson, Merck, Forest, Otsuka, Purdue, Takeda, Pfizer, Shire, Sunovion, and SyneuRx. He is a consultant to Sunovion. Dr. Strawn has received research support from Edgemont, Forest Research Institute/Allergan, Lundbeck, Shire, Neuronetics and the National Institute of Mental Health (NIMH and NIEHS). He receives royalties from Springer Publishing and UpToDate and has received material support from Assurex. Dr. Strakowski has recently received research grants from Janssen, Otsuka, the Michael and Susan Dell Foundation and the NIMH; he serves as DSMB chair for Sunovion. Dr. DelBello has received research support from Amarex, Johnson and Johnson, Pfizer, Otsuka, Shire, Sunovion, Supernus and Lundbeck. She is a consultant to Akili, CMEology, Johnson and Johnson, Lundbeck, Neuronetics, Pfizer, Sunovion, Supernus, and Takeda. The remaining authors declare no conflicts of interests.